Table 1 Demographic and clinical characteristics in patients with chronic neuropathic pain (CNP) and acute pain (ACP) after herpes Zoster.

From: Downregulation of EAAT-2 impairs chronic neuropathic pain via increasing of plasma glutamate after herpes zoster infection

 

ACP

(N = 51)

CNP

(N = 51)

p

Gender

 Female

29 (56.9%)

24 (47.1%)

0.428

 Male

22 (43.1%)

27 (52.9%)

 

Age (year)

61 ± 11.2

64.7 ± 13.1

0.186

Sites

 Abdomen

7 (13.7%)

3 (5.9%)

0.417

 Abdomen and back

3 (5.9%)

9 (17.6%)

 

 Back

9 (17.6%)

10 (19.6%)

 

 Chest

2 (3.9%)

3 (5.9%)

 

 Chest and back

18 (35.3%)

13 (25.5%)

 

 Head

9 (17.6%)

11 (21.6%)

 

 Limb

3 (5.9%)

2 (3.9%)

 

Duration (month)

1.7 ± 0.5

6.6 ± 4.0

< 0.001

Peak time (week)

1.4 ± 0.6

2.0 ± 0.7

< 0.001

Area

 Large

8 (15.7%)

10 (19.6%)

0.437

 Mid

24 (47.1%)

28 (54.9%)

 

 Small

19 (37.3%)

13 (25.5%)